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Abstract
Cdc6p is an essential component of the pre-replicative complex (pre-RC), which binds to DNA replication origins to promote
initiation of DNA replication. Only once per cell cycle does DNA replication take place. After initiation, the pre-RC
components are disassembled in order to prevent re-replication. It has been shown that the N-terminal region of Cdc6p is
targeted for degradation after phosphorylation by Cyclin Dependent Kinase (CDK). Here we show that Mck1p, a yeast
homologue of GSK-3 kinase, is also required for Cdc6 degradation through a distinct mechanism. Cdc6 is an unstable
protein and is accumulated in the nucleus only during G1 and early S-phase in wild-type cells. In mck1 deletion cells, CDC6p
is stabilized and accumulates in the nucleus even in late S phase and mitosis. Overexpression of Mck1p induces rapid Cdc6p
degradation in a manner dependent on Threonine-368, a GSK-3 phosphorylation consensus site, and SCFCDC4. We show
evidence that Mck1p-dependent degradation of Cdc6 is required for prevention of DNA re-replication. Loss of Mck1 activity
results in synthetic lethality with other pre-RC mutants previously implicated in re-replication control, and these double
mutant strains over-replicate DNA within a single cell cycle. These results suggest that a GSK3 family protein plays an
unexpected role in preventing DNA over-replication through Cdc6 degradation in Saccharomyces cerevisiae. We propose
that both CDK and Mck1 kinases are required for Cdc6 degradation to ensure a tight control of DNA replication.
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Introduction
To constitute the pre-RC and initiate DNA replication, all six-
components of the Origin Recognition Complex (Orc1-6p) bind to
replication origins followed by Cdc6p, Cdt1p and the Mcm2-7p
complex [1]. Then the pre-RC has to be activated by the Dbf
kinase-Cdc7p complex, resulting in the formation of a bidirec-
tional replication fork in which the Mcm complex acts as a
replicative helicase [1]. Finally, DNA polymerase synthesizes new
strands of DNA. The cell cycle progression is driven by the
Cyclin/CDK complex. Of the nine cyclins in S. cerevisiae six are B-
type cyclins (Clb1-6) [2] and there is a single CDK (Cdc28).
Cdc28-Clb activity is required to initiate DNA replication [3–5].
Eukaryotes ensure that DNA is replicated once and only once
per cell cycle. There are multiple overlapping mechanisms to
prevent re-initiation of DNA replication. Pre-RC components
such as Cdc6, Mcm2–7, and the ORC complex are phosphor-
ylated by Cyclin/CDK to prevent a second round of DNA
replication from occurring before mitosis. Cdc6 is phosphorylated
by Cyclin/CDK complex at the N-terminal region and is targeted
for ubiquitin-mediated proteolysis in S. cerevisiae [6–8]. The MCM
complex is translocated to the cytoplasm after phosphorylation by
Cdk activity [9,10]. Orc2 and Orc6 are also phosphorylated in a
CDK-dependent manner [11,12]. In addition to these mecha-
nisms, a direct recruitment of the cyclin-CDK complex Clb5p-
Cdc28p to the origin of replication is an important component of
re-replication control [13]. The Clb5p recruitment to the origin is
accomplished by binding of the Clb5p hydrophobic patch
substrate-targeting domain [14–16] to an Arg-X-Leu (RXL) target
sequence in the Orc6p subunit of the ORC origin recognition
complex [13]. This Clb5 binding to Orc6 after origin licensing
serves as a local switch to inhibit DNA re-replication by preventing
Cdt1/Mcm2–7 loading onto the origin [17]. The ORC6-rxl
mutation strongly synergized with other mutations previously
implicated in re-replication control including: N-terminal deletions
in Cdc6 which stabilize the protein (CDC6DNT) [13], mutations
which force nuclear localization of the Mcm complex (MCM7-
NLS) [11], and mutations blocking Orc2 (ORC2-ps) and Orc6
phosphorylation (ORC6-ps) [18]. Such multiple mutant strains
strongly over-replicate DNA within a single cell cycle [13].
ORC6-rxl GAL-CDC6DNT cells are viable, but show moderate
DNA re-replication when incubated in galactose [19]. The cell
cycle in the ORC6-rxl GAL-CDC6DNT cells arrest at G2/M phase
due to DNA damage checkpoint activation [19]. Moderate cell
viability in the ORC6-rxl GAL-CDC6DNT cells was heavily
dependent on DNA damage checkpoint components such as
MRE11 gene. Cell viability was reduced and DNA re-replication
was enhanced in mre11 ORC6-rxl GAL-CDC6DNT cells [19]. It is
known that Rad53 is phosphorylated upon DNA damage
checkpoint activation. Rad53 was hyperphosphorylated in
ORC6-rxl GAL-CDC6DNT cells [19], suggesting that DNA damage
was induced. We concluded that DNA re-replication most likely
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causes double strand breaks which in turn activates the DNA
damage checkpoint response [19].
To identify a new component that inhibits DNA re-replication
in S. cerevisiae, synthetic genetic array (SGA analysis) [20] was
performed using an ORC6-rxl strain to eliminate Clb5-Orc6
binding. We found that mck1 deletion cells combined with the
ORC6-rxl mutation showed synthetic lethality. The MCK1 gene in
S. cerevisiae encodes a serine/threonine protein kinase homologous
to mammalian glycogen synthase kinase-3 (GSK-3) [21]. Mam-
malian GSK-3 was initially identified as an enzyme involved in the
control of glycogen metabolism [22]. GSK-3 kinase is highly
conserved through evolution and plays an important role in the
Wnt signaling pathway in the mammalian system (for a review, see
[23]). One of the interesting features of GSK-3 kinase is its role in
protein degradation. GSK-3 phosphorylates cyclin D1 to promote
its nuclear export and subsequent degradation in the mammalian
system [24]. Yeast Mck1p has diverse biological functions. Mck1p
stimulates calcineurin signaling [25–27] and binds stress-response
elements to activate transcription [27] therefore cells lacking
Mck1p are hot and cold sensitive [28]. Mck1 is also implicated in
mitosis and meiosis. Yeast MCK1 has been isolated as a dosage
suppressor of centromere (CEN) DNA mutation in CDEIII,
suggesting that Mck1 has a role in centromere/kinetochore
function [28]. The mck1 mutant exhibits poor sporulation [29],
and sensitivity to benomyl, a microtubule destabilizing drug [28].
Cdc6 levels are regulated by three distinct mechanisms:
transcription [30], ubiquitin-mediated proteolysis [7,8,31,32] and
nuclear localization [33]. Here we show that Mck1p has a novel
function in inhibition of DNA re-replication by Cdc6p degrada-
tion through the GSK-3 consensus site at T368.
Results
Deletion of MCK1 causes synthetic lethality in the orc
mutants
Synthetic genetic array (SGA analysis) [20] was performed using
ORC6-rxl, to eliminate Clb5-Orc6 binding, in order to identify a
new component in the regulation of DNA re-replication in S.
cerevisiae. We found that mck1 deletion cells showed synthetic
lethality in cells containing the ORC6-rxl mutation. It is interesting
that mck1 was the only deletion strain that caused synthetic
lethality in the ORC6-rxl cells among 4700 deletion strains tested,
and that we did not obtain other GSK-3 orthologs in this
screening. Tetrad analysis confirmed the genetic interaction
between ORC6-rxl and mck1 deletion strains (Figure 1A). Haploid
progenies, which contain both ORC6-rxl and Dmck1 mutations,
were not able to grow on YEPD plates whereas single mutants
grew fine. We also tested if the mck1 deletion genetically interacts
with the other orc mutants such as the Orc6 phosphorylation site
mutant (ORC6-ps) and the Orc2 phosphorylation site mutant
(ORC2-ps). Deletion of MCK1 reduced cell growth in the ORC6-ps
cells (Figure 1A). Furthermore, the mck1 deletion caused severe
growth defects in the ORC2-ps cells (Figure 1A). Thus, mck1
deletion caused synthetic lethality or semi-lethality with DNA re-
replication-prone orc mutants in general. This strongly suggests
that Mck1p has a function in DNA replication control. The mck1
deletion strain did not have genetic interactions with other pre-RC
mutants such as MCM7-NLS or CDC6DNT (data not shown).
Combination of mck1 deletion and ORC6-rxl mutation
induced DNA damage checkpoint activation
To investigate the molecular basis of the synthetic lethality
between Dmck1 and ORC6-rxl, we generated partial loss of function
mutants of mck1 by PCR mutagenesis. Among them, mck1-16 allele
exhibited semi-synthetic lethality at high temperature (36 degrees)
when combined with ORC6-rxl mutation (Figure 1B). Consistent
with this effect being due to the disruption of Clb5-Orc6 protein
interaction by the ORC6-rxl mutation, the clb5 mck1-16 cells were
also semi-lethal when incubated at 36 degrees (Figure 1B). To
analyze the terminal phenotype of the mck1-16 ORC6-rxl strain,
cells were incubated either at permissive or non-permissive
temperatures and cell cycle profiles were analyzed by flow
cytometry analysis. The mck1-16 ORC6-rxl cells showed G2/M
arrest after 4 hours incubation at 36 degrees (Figure 1C, top
right), with some cells showing a DNA content over 2C (Figure 1C,
arrow), suggesting re-replicated DNA. Cell morphologies of the
mck1-16 ORC6-rxl mutants were further analyzed. The mck1-16
ORC6-rxl cells incubated at 36 degrees for 4 hours showed large
budded cells with a single nuclei visualized by propidium iodide
staining of DNA (Figure 1D). This phenotype is reminiscent of
cells with DNA re-replication found in our previous report [19].
Nuclear division did not occur in the mck1-16 ORC6-rxl cells. Their
cell cycle is arrested during G2 or early mitosis, most likely due to
DNA damage checkpoint activated by DNA re-replication. This is
similar to our previous observation that mitotic arrest in the
ORC6-rxl CDC6DNT cells was due to DNA damage [19].
Previously we have shown that the ORC6-rxl mutant causes
semi-synthetic lethality with a CDC6DNT mutant. The ORC6-rxl
CDC6DNT cells are arrested during mitosis with moderate DNA
re-replication followed by DNA damage. Viability of the ORC6-rxl
CDC6DNT cells was heavily dependent on an intact DNA damage
checkpoint gene such as MRE11, a component of the MRX
complex [19]. Rad53, a transducer kinase required for DNA
damage checkpoint activation, was hyperphosphorylated in the
ORC6-rxl CDC6DNT cells. To directly test if DNA damage
checkpoint is activated in the mck-16 ORC6-rxl cells, Rad53
phosphorylation status was analyzed by Western blotting. Rad53
was only hyperphosphorylated in the mck-16 ORC6-rxl cells when
incubated at 37 degrees (Figure 2A). We tested if the viability of
the mck1-16 ORC6-rxl mutant also relies on DNA damage
checkpoint. We found that cell viability of the mck-16 ORC6-rxl
cells even at the permissive temperature (30 degrees) required
MRE11 (Figure 2B). Next, the cell cycle profile of the mre11 mck-16
ORC6-rxl cells was examined. DNA re-replication was greatly
enhanced in the mre11 mck-16 ORC6-rxl cells at the non-permissive
temperature, indicating that DNA damage checkpoint activation
limits DNA re-replication in the mck-16 ORC6-rxl cells (Figure 2C).
Above all, we conclude that an induction of DNA re-replication in
the mck-16 ORC6-rxl cells triggered DNA damage leading to cell
cycle arrest by DNA damage checkpoint activation.
Author Summary
DNA replication is a fundamental cellular process that
takes place in all living organisms. This cellular event has to
be tightly regulated to ensure an accurate genome
integrity such that DNA replication takes place only once
per cell cycle. Here we show a mechanism by which DNA
re-replication is controlled by Cyclin Dependent Kinase
(CDK) and a yeast GSK-3 kinase (Mck1p) in S. cerevisiae. We
found that Mck1p promoted Cdc6 protein degradation.
Mck1p targets Cdc6p through a GSK-3 consensus site
(T368), and Cdc6p protein degradation was also mediated
through the same T368 site. The GSK-3 kinase has diverse
cellular functions in higher eukaryotes including roles in
tumorigenesis. This finding is particularly important, since
this is the first evidence to show that a GSK-3 family kinase
regulates DNA replication.
Cdc6p Degradation by a Yeast GSK-3 Kinase
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Mck1 prevents DNA re-replication in parallel to ORC and
MCM complexes
Several parallel and partially overlapped molecular mechanisms
ensure that cells do not re-initiate DNA replication at origins that
have already fired. We have previously shown that ORC6-rxl
CDC6DNT cells are mitotic arrested without extensive DNA re-
replication [19]. However, multiple mutant strains such as ORC6-
rxl,ps CDC6DNT MCM7-NLS ORC2-ps strongly over-replicate
DNA within a single cell cycle [13]. We tested if mck1 deletion
also synergizes with other pre-RC mutations. An addition of either
MCM7-NLS or ORC2-ps mutation to the ORC6-rxl mck1-16 did not
enhance lethality (Figure 3A). However, cells containing ORC6-
rxl,ps mck1-16 MCM7-NLS and ORC2-ps mutations showed
stronger lethality (Figure 3A). Flow cytometry analysis showed
that DNA re-replication was enhanced in the ORC6-rxl,ps mck1-16
MCM7-NLS ORC2-ps mutant after 4 hours incubation at the non-
permissive temperature (Figure 3B, bottom right). ORC6-rxl,ps
MCM7-NLS ORC2-ps cells with wild type MCK1 grew normally
and did not induce significant re-replication (Figure 3A and 3B
bottom left). These results show that Mck1p contributes to the
Figure 1. Synthetic lethality and mitotic arrest was induced in the ORC6-rxl mck1-16 cells. (A) ORC-x::LEU2::HIS3/ORC6 mck1/MCK1-wt
diploid strains were sporulated, tetrads were dissected on YEPD plates, and the plates were incubated for 3 days at 30uC. ORC6 alleles and mck1
deletion were identified based on the markers. Inviable spores were genotyped by assuming a 2:2 segregation. The ORC6-rxl, ORC6-ps or ORC2-ps
alleles were indicated above each panel. The presence of ORC6 mutant allele was marked as (m) and ORC6 wild type as (+) on the left. The presence of
mck1 mutant allele (m) or MCK1-wt (+) was indicated on the right. (B) Strains with indicated genotypes were serially diluted 10 fold and plated on
YEPD plates to test viability at different temperatures. The plates were incubated at the indicated temperature for 1–2 days. (C) Asynchronus
populations of strains with indicated genotypes were grown at 26uC first. The temperature was shifted to 36uC and the samples were collected after
4 hours. The cells were fixed, stained with propidium iodide and analyzed by FACS. (D) Wild type, mck1-16 or ORC6-rxl mck1-16 cells were incubated
at 36uC for 4 hours, and observed under the fluorescent microscope. Red color indicates nuclei stained by propidium iodide.
doi:10.1371/journal.pgen.1003099.g001
Cdc6p Degradation by a Yeast GSK-3 Kinase
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inhibition of DNA re-replication and suggest that the mechanism
involved is likely to be distinct from the known mechanisms acting
at the level of ORC and MCM proteins.
The mck1 deletion strain genetically interacted with S-
phase cyclins, but not mitotic cyclins
The semi-lethal phenotype of ORC6-rxl Dmck1 cells (Figure 1D)
was reminiscent of ORC6-rxl CDC6DNT cells [13]. Moreover, the
deletion of MCK1 interacted genetically with ORC6-rxl (Figure 1A)
but not CDC6DNT (data not shown). These observations led us to
hypothesize that Mck1p could function in DNA replication control
by regulating Cdc6. To further test this model, we examined if
mck1 deletion behaved similarly to CDC6DNT in its interactions
with mutations in the cyclin genes.
CDC6DNT genetically interacts with the clb5 deletion mutant,
but not with other B-type cyclins [34]. We also tested if mck1
deletion cells genetically interact with other cyclin mutants in a
similar way that CDC6DNT does. Table 1 summarizes the genetic
interaction between mck1 and cyclin mutants. The mck1 deletion
cells were semi-lethal in the ORC6-rxl mutant cells and also showed
synthetic lethality with clb5 deletion cells because ORC6-rxl is a
binding mutant for Clb5p. However, the mck1 deletion cells did
not cause synthetic lethality with other B-type cyclin mutants such
as clb1,2,3,4 or 6 (Table 1). Therefore, mck1 deletion genetically
interacts specifically with clb5 deletion. It has been shown that
Clb5p binds to Orc6p through the Clb5p hydrophobic patch
substrate-targeting domain [14]. We tested if clb5-hpm (Clb5
hydrophobic patch mutant) causes synthetic lethality with Dmck1
cells and found that there was a genetic interaction between clb5-
hpm and Dmck1 (Table 1). Moreover neither mck1 nor CDC6DNT
caused lethality in clb5pCLB2, a mutant in which Clb2 is controlled
under Clb5 promoter. Thus, we conclude that the Dmck1 cells
require Clb5p-Orc6p protein binding for their survival. We also
found that deletion of CLB6 rescues Dmck1 Dclb5 semi-lethality.
We have previously shown that lethality in clb5 CDC6DNT cells
can be rescued by the deletion of CLB6 [34] and proposed the idea
that the S-phase cyclin Clb6 initiates DNA replication, but fails to
inhibit DNA re-replication. Therefore, the DNA re-replication
phenotype is suppressed if CLB6 is deleted by the reduction of
initiation of DNA replication. Mitotic cyclins regulate DNA
replication in the clb5 clb6 ORC6-rxl cells. We speculate that
deletion of CLB6 rescues Dmck1 Dclb5 cells in the same manner.
From these results we conclude that the mck1 deletions
genetically interacted with cyclin mutants in a way similar to that
of stabilized CDC6DNT, reinforcing a model in which Mck1p acts
in the same pathway as Cdc6p.
Mck1p kinase is required for Cdc6p degradation in
mitosis
Because lack of Mck1p and stabilization of Cdc6p (Cdc6DNT)
exhibited similar genetic interaction with DNA re-replication
mutants, we speculated that Mck1p could control the stability of
Cdc6p. To test this possibility, the Cdc6 protein (Cdc6-HA)
expressed under inducible GAL1 promoter in mitotically arrested
cells was examined in wild type or Dmck1 backgrounds. We found
that the Cdc6 protein level was sustained at a higher level during
mitosis in the mck1 deletion cells than in wild type cells even after
Cdc6 expression was shut off by glucose (Figure 4A). It is
Figure 2. DNA damage was induced in ORC6-rxl mck1-16 cells. (A) ORC6-rxl mck1-16 cells were incubated either at 25 or 37uC and their protein
extract was subjected to western blot analysis to detect Rad53-FLAG. (B) Strains with indicated genotypes were serially diluted 10 fold and plated on
YEPD plates. The plates were incubated at the indicated temperature for 1–2 days. (C) Asynchronus populations of strains with indicated genotypes
were grown at 25uC first. The temperature was shifted to 37uC for 8 hours and samples were collected. The cells were fixed, stained with propidium
iodide and analyzed by FACS.
doi:10.1371/journal.pgen.1003099.g002
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important to mention that CDC6 was expressed under the GAL1
promoter, excluding possible involvement of CDC6 transcription
by Mck1 in this experiment. To test if Mck1 regulates Cdc6p post-
translational levels, endogenous Cdc6 synthesis was blocked by
cycloheximide. In the mitotically arrested wild type cells, Cdc6
protein was rapidly depleted by addition of cycloheximide (Figure
S1). In the mitotic mck1 deletion cells, the cdc6 protein level was
high and remained stable after cycloheximide, excluding the
possibility that Mck1p regulates Cdc6p by translation. These
results strongly suggest that Mck1p controls Cdc6 protein levels by
affecting degradation rates.
To further explore the possible involvement of Mck1p in Cdc6p
degradation, Protein A-tagged Cdc6 protein integrated at the
genome locus was examined in the wild type or mck1 deletion cells
by Western blotting throughout a single cell cycle progression. We
noticed a dramatic accumulation of Cdc6 protein in the mck1
deletion cells (Figure 4B). In wild type cells, Cdc6p was expressed
transiently during G1 phase, 10 minutes after alpha-factor release,
and suppressed throughout S-phase. Then Cdc6p was expressed
again for a short time during mitosis, 70 minutes after alpha-factor
release (Figure 4B, upper panel). This is consistent with a previous
report by Drury et al [32]. While in the mck1 deletion cells, Cdc6p
was not expressed during alpha-factor arrest but was expressed
10 min after alpha-factor release and continued to accumulate
during S-phase and mitosis (Figure 4B, lower panel). The increase
in Cdc6 protein level is unlikely to be due to an alteration in the
Figure 3. Mechanism of DNA re-replication control by Mck1 kinase is additive. (A) Cells with indicated genotypes were plated with a 10-
fold dilution on YEPD plates. The plates were incubated at indicated temperatures for 2 days. (B) Asynchronus population cells with indicated
genotypes (with wild type MCK1 or with mck1-16 mutation) were incubated at 26uC first and then shifted to 36uC for 4 hours. Cells were fixed, stained
by propidium iodide and analyzed by FACS. Percentage of the cell population over 2C DNA content is shown.
doi:10.1371/journal.pgen.1003099.g003
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cell cycle progression of Dmck1 cells because the kinetics of the cell
cycle progression was similar in these two strains as judged by
budding index (Figure 4B). To confirm that Cdc6p is stabilized
during mitosis in the mck1 deletion strain, CDC6-ProteinA or mck1
CDC6-ProteinA strains were arrested in mitosis by nocodazole and
were synchronously released into the cell cycle by washing. A small
amount of Cdc6p was detectable at time zero in nocodazole
arrested wild type cells (Figure 4D, left). This amount was
transiently increased 10–20 minutes after release. This is consis-
tent with a previous report that Cdc6 protein is expressed in late
mitosis and degraded after the G1/S transition [7]. In contrast,
Cdc6p was stabilized throughout mitotic progression in the mck1
deletion cells (Figure 4D, right).
To further confirm if Cdc6 is stabilized in the mck1 deletion
cells, we visualized Cdc6p localization in vivo. We introduced a
GFP-tag into the C-terminus of the chromosomal copy of the
CDC6 gene to allow endogenous expression. The CDC6-GFP
fusion appears to be fully functional as a CDC6-GFP strain and did
not show any growth defect in any of the conditions tested (data
not shown). Consistent with previously published localization
patterns of overexpression, Cdc6-GFP [33,35] protein localized
and accumulated in the nucleus in late mitotic cells (large budded
cells with divided nuclei) or in unbudded G1 cells (Figure 4C). The
Cdc6-GFP signal was undetectable in the cells with small to large
buds, confirming tight regulation of Cdc6 abundance by rapid
degradation after S-phase onset. In sharp contrast, Cdc6-GFP was
constitutively found in the nucleus throughout the cell cycle in
mck1 deletion cells (Figure 4C). This localization analysis was
consistent with Western blot results that Cdc6p is stabilized in mck1
deletion cells during S-phase and mitosis, as shown in Figure 4B
and 4D.
We also tested if overexpression of Mck1 promotes rapid Cdc6p
degradation. Exogenously expressed Mck1p under the GALL
promoter significantly reduced Cdc6p protein levels 10 minutes
after the addition of galactose (Figure 5A, top right). This result
supports the idea that Mck1p promotes Cdc6p degradation.
Mck1-mediated Cdc6 degradation was inhibited in cdc4-
1 mutant
We next examined if Mck1-mediated Cdc6 degradation is due
to SCFCDC4 ubiquitin ligase. When cdc4-1 CDC6-prA mck1 GALL-
MCK1 strain was incubated at 26 degrees, Cdc6p was rapidly
degraded followed by galactose addition (Figure 5B). This is
consistent with results in Figure 5A. When Cdc4 was inactivated at
36 degrees, Cdc6 became stable and was not degraded even after
Mck1 overexperssion (Figure 5B). This result suggests that Mck1p
phosphorylates Cdc6p to be subsequently recognized by SCFCDC4
complex for degradation.
Mck1p binds to Cdc6p through a GSK-3 consensus site in
the C-terminal region
GSK-3 kinases phosphorylate the first serine or threonine residues
in the consensus site followed by a phospho-serine or phospho-
threonine at the position +4 [S/T-XXX-pS/T] [36]. There are two
potential GSK-3 consensus phosphorylation sites in Cdc6p, TPESS
(39–43) and TPTTS (368–372) (Figure 6A). To test if Mck1p binds
Cdc6p at the GSK-3 consensus sites, we performed a yeast two-
hybrid assay. We examined whether Mck1p, fused with Gal4
activation domain (GAD), interacts with various truncated CDC6
mutants fused to the LexA DNA binding domain. Mck1p interacted
with the C-terminal region of Cdc6p (aa341–390) and not with the
N-terminus (aa 1–47) (Figure 6B). The mutation at T368M or
S372A abolished two-hybrid interaction between Mck1p-Cdc6p
indicating that Mck1p targets Cdc6p through the GSK consensus
site at 368–372 (Figure 6B). The physical interaction between Mck1p
and Cdc6p was also confirmed by co-immunoprecipitation (Co-IP)
assay using the MCK1-MYC GAL-CDC6DNT-HA strain. Mck1p
interacted with Cdc6DNTp, indicating that Mck1p interacts with
Cdc6p, and the protein interaction was mediated through the C-
terminal region in Cdc6p (Figure 6C). The protein binding between
Mck1p and Cdc6p was observed only in mitotic arrested cells
blocked by nocodazole and not in asynchronous culture or G1-
arrested cells (data not shown). Therefore the physical interaction
between Mck1p and Cdc6p is likely primed by mitotic CDK
phosphorylation of the S372 site (see next section). We also noticed
that Cdc6DNT migrates slower in the co-IP samples than the input,
consistent with the idea that only the phosphorylated form of Cdc6,
probably targeted by CDK, binds to Mck1 (Figure 6C).
CDC6 mutations that abrogate GSK-3 binding are lethal
with the orc mutants
A GSK-3 kinase usually requires priming [36]. In Cdc6, the
predicted priming site is located at S372 based on the amino acid
sequence. After priming, the GSK-3 kinase phosphorylates the
target site at the first serine or threonine that corresponds to T368
(see discussion). Next, we tested to see if mutations at the GSK-3
consensus phosphorylation site in CDC6 cause lethality in orc
mutants like the mck1 deletion does. To prove that the C-terminus
GSK-3 consensus site 368–372 in CDC6 was involved in the
inhibition of DNA re-replication, the potential phosphorylation
site (T368) and the priming phosphorylation site (S372) were
altered to alanine. The CDC6-T368A S372A in a 2 micron plasmid
was transformed into wild type, ORC6-rxl, ORC6-ps or ORC6-rxl,ps
mutants. Colonies formed when either CDC6 wild type or CDC6
T368A S372A plasmids were transformed into the ORC6-wild type
strain (Figure 7B, top left). In contrast, the CDC6 T368A S372A
plasmid (but not CDC6-wt) was toxic in the ORC6-rxl cells, as
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transformants gave very few visible colonies (Figure 7B, top right).
This effect was even more pronounced in ORC6-rxl,ps cells and, in
this case, even the CDC6-wt plasmid appeared somewhat toxic
(Figure 7B, bottom right). The CDC6-T368A S372A plasmid did
not induce toxicity in the ORC6-ps cells (Figure 7B, bottom left)
which confirmed the result that mck1 did not genetically interact
with ORC6-ps mutation (Figure 1). The plasmid harboring CDC6-
T368A or CDC6-S372A single mutation was also toxic in the
ORC6-rxl strain (Figure S2). These results suggest that the
interaction of Cdc6p with Mck1p and/or its phosphorylation by
Mck1p contributes to the down-regulation of Cdc6p levels.
Mck1p phosphorylates Cdc6 for its degradation
To confirm that Cdc6p is phosphorylated by Mck1 in vivo, we
analyzed the Mck1-dependent mobility shift of Cdc6p in the cdc4-1
mutant background by western blot. We used cdc4-1 mutant to
prevent degradation of phosphorylated Cdc6 and examined the
effect of Mck1 on the phosphorylation status of Cdc6p. Cdc6p in
Figure 4. Mck1p is required for Cdc6p degradation. (A) GAL-CDC6-HA (WT) or Dmck1 GAL-CDC6-HA (Dmck1) cells were incubated in raffinose
first, then transferred to galactose media for 2 hours. Nocodazole was added and the cells were incubated for 2 more hours. Cdc6 expression was
suppressed by adding glucose. Samples were collected every 5 minutes. Protein extracts were made and subjected to western blot analysis to
observe Cdc6-HA. Pgk1 was used as a loading control. (B) CDC6-prA or Dmck1 CDC6-prA cells were treated with alpha-factor to arrest the cell cycle
during G1 phase. The cells were released from G1 and collected every 10 minutes. Proteins were extracted from each sample and subjected to
Western blot analysis to detect Cdc6-prA. Budding index is shown using the same samples. (C) Localization of Cdc6-GFP was analyzed in living cells.
In wild type cells, nuclear accumulation of Cdc6-GFP was observed only in late mitotic cells (arrowhead) and not in small to medium budded cells
(arrows), whereas Cdc6-GFP was observed in the nucleus throughout the cell cycle (arrowheads) in mck1 deletion cells. (D) CDC6-prA or Dmck1 CDC6-
prA cells were blocked at metaphase by nocodazole. The mitotic arrest was released upon removal of the drug. Cells were then incubated in YEPD
and collected every 10 minutes. Proteins were extracted subjected to western blot analysis to detect CDC6-prA. Pgk1 was used as a loading control.
doi:10.1371/journal.pgen.1003099.g004
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the wild type cells migrated slower that that in the Dmck1 deletion
cells indicating that Cdc6p is hyper-phosphorylated in wild type
cells. (Figure 7C). In the mck1 deletion cells, the signal of the higher
molecular weight band was abrogated and the lower band was
abundant suggesting that Cdc6p is less phosphorylated and more
stable (Figure 7C right). To confirm that the slow migrating band
of Cdc6p in the wild type cells is due to phosphorylation, protein
extracts from wild type cells were treated with CIP (calf intestine
phosphatase). After the CIP treatment, the slower migrating band
of Cdc6p disappeared and the faster-migrating band was observed
at the same level as that in Dmck1 cells. It suggests that the band
shift between wild type and Dmck1 is due to phosphorylation
(Figure 7C and 7D).
Finally we tested if Mck1p dependent destabilization of the
Cdc6p is mediated by the T368 residue. The mck1 GALL-MCK1
CDC6-proteinA CDC6T368A strain contains both wild type Cdc6
(tagged with protein A) and Cdc6T368A (no tag). First the cells
were arrested in mitosis with nocodazole and then released into
galactose to overexpress Mck1p. Wild type Cdc6p was degraded
rapidly after Mck1p overexpression, which is consistent with
previous results in Figure 5A (Figure 7E, upper panel). In contrast,
Cdc6T368A protein was resistant to degradation and was stable
even after Mck1p overexpression (Figure 7E, lower panel). We also
observed faster migration of Cdc6T368A protein than the wild
type Cdc6p by western blot (Figure S3). We conclude that Cdc6p
is phosphorylated at T368 by Mck1p to induce its degradation.
Discussion
In this study, we show that a GSK-3-like kinase, Mck1p, is
involved in the inhibition of DNA re-replication through its role in
Cdc6p turnover in S. cerevisiae. There are 8 CDK consensus sites in
CDC6. The first 47 amino acids at the N-terminus of Cdc6 are
targeted by Cyclin/CDK and are critical for SCFcdc4 dependent
proteolysis [7]. Stabilization of Cdc6p in mck1 deletion cells
suggests that CDK-dependent phosphorylation at the N-terminus
of Cdc6 is not sufficient enough for CDC6p degradation in vivo,
that Mck1-dependent phosphorylation through T368 site is also
required. The Cdc6 T368A mutant was resistant to Mck1p-
dependent degradation (Figure 7E). Nocodazole was added to the
media throughout this experiment, therefore Cdc6 stabilization by
the T368A mutation, even after Mck1p overexpression, is not due
to a change in cell cycle progression. This is of particular interest
because activation of CDK promotes both DNA replication and
Cdc6p degradation at the same time. The requirement of Mck1
for Cdc6p degradation most likely ensures that degradation of
Cdc6p occurs only after origin firing has been initiated.
Three distinct Cdc6p degradation modes have been proposed
by Diffley’s group [32]. Mode1 degradation during G1 phase is
independent of Cdc6 CDK consensus sites and is mediated neither
by SCF nor APC. The Cdc6p degradation by Mode 2 and Mode 3
are triggered later during the cell cycle. Mode3 is required for
Cdc6 degradation during mitosis. The Cdc6p degradation by
Figure 5. Rapid degradation of Cdc6p by Mck1p overexpression was inhibited in cdc4 mutant. (A) First, the Dmck1 GALL-MCK1 CDC6-prA
cells were incubated in glucose plus nocodazole in order to arrest the cell cycle during mitosis. Then, the nocodazole was removed and the media
was switched to either glucose or galactose. Samples were taken every 10 minutes, proteins were extracted and subjected to western blotting as
described above. Control experiments were performed using Dmck1 CDC6-prA cells to show that galactose does not affect Cdc6 level. Pgk1 was used
as a loading control. (B) cdc4-1 CDC6-prA Dmck1 GALL-MCK1 strain was incubated in raffinose-containing media first. The cell cycle was blocked by
nocodazole and then the cells were further incubated either at 26uC or 36uC for 1.5 hours. Galactose was added to the media, samples were collected
every 10 minutes and the protein extracts were subjected to western blotting to detect Cdc6-prA. Pgk1 was used as a loading control.
doi:10.1371/journal.pgen.1003099.g005
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Mck1p accounts for the mode3 mechanism based on the Cdc6p
stabilization pattern during mitosis in mck1 deletion (Figure 4A).
Diffley’s group has reported that the Cdc6 T368M mutation leads
to Cdc6p stabilization during mitosis and the mutation is resistant
to mode 3 proteolysis by SCFcdc4 complex [6]. In this study, we
showed that Mck1-dependent Cdc6 phosphorylation is targeted by
SCFCDC4 complex for degradation (Figure 5B). Therefore, Mck1,
most likely, phosphorylates Cdc6 and the phosphorylation at T368
is recognized by Cdc4. It is not clear if mode 3 requires CDK
activity. Therefore Mck1p may promote complete Cdc6 degra-
dation during mitosis in addition to its degradation mechanism
through CDK phosphorylation. Further studies are required to
test if Mck1 could also promote Cdc6 degradation via Mode 1 or
Mode 2.
There are two potential GSK-3 sites S/TXXXpS/T in Cdc6,
at 39-43 and 368-372 amino acid residues. It has been reported
that these sites share sequence similarities and are targeted for
SCFCDC4 dependent proteolysis [6]. Our yeast-two hybrid assay
showed a specific interaction between Mck1p and Cdc6p through
the GSK-3 consensus site located at residues 368–372 (TPTTS).
This GSK-3 site in Cdc6p, amino acid 368–372, is also shared by
two potential CDK phosphorylation sites 368–371 (TPTT) and
372–275 (SPVK). The former partially matches with a minimal
consensus CDK phosphorylation site (S/T-P) whereas the latter
perfectly matches an optimal CDK site, with a basic residue at the
+3 position. It is important to note that Cdc6 is a very good
substrate of the B-type Cyclin/CDK complex [37]. The GSK-3
kinase and CDK could share substrate specificity [38]. GSK-3
kinases require ‘‘priming’’ phosphorylation by another kinase on
their substrates [36]. The priming site is usually located C-
terminally of the GSK-3 phosphorylation site, at the +4 position,
which corresponds to S372 in Cdc6. After priming, GSK-3
recognizes its target and can phosphorylate the first serine or
threonine residue, which corresponds to T368 in Cdc6. Thus, C-
Figure 6. Mck1p interacts with Cdc6p through the GSK-3 consensus site in the C-terminal region. (A) Cdc6 contains eight CDK consensus
sites, S/TP motif indicated by short lines (top). The Cdc6DNT mutant lacks the N-terminal region, from amino acid 2–49, thereby lacking the first four
CDK sites (bottom). The GSK-3 consensus sites located at 39–43 and 368–372 are indicated by short red lines. (B) Yeast two hybrid analysis was
performed to determine the binding site between Mck1p and Cdc6p. A full length MCK1 in pACT plasmid, containing the GAL4 activation domain
(GAD), was co-transformed into L40 yeast strains along with the various CDC6 mutants in the pBTM116 plasmid fused to LexA. Transformants were
assayed for b-galactosidase activity as visualized in blue. (C) Co-immunoprecipitation analysis was performed using MCK1-MYC CDC6DNT-HA, MCK1-
MYC or CDC6DNT-HA strain. Cells were incubated in raffinose to log phase and then switched to Galactose to induce GAL-CDC6DNT. After 2 hour
incubation, nocodazole was added to the media in order to block cell cycle during G2/M. The cells were incubated for two more hours and protein
was extracted. The protein lysate from each strain was incubated with agarose beads conjugated with anti-MYC to pull down the Mck1 complex. The
protein complex was subjected to western blotting to analyze Mck1-MYC or Cdc6DNT-HA using anti-MYC or anti-HA antibodies, respectively. 1/50 of
the original protein lysate was used as INPUT.
doi:10.1371/journal.pgen.1003099.g006
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terminal Cdc6p (aa 341–390), including the GSK-3 consensus
phosphorylation sequence, is sufficient for Mck1 binding and their
interaction likely depends on phosphorylation of S372 by CDK
(Figure 6B). We propose a model in which S372 is phosphorylated
by cyclin/CDK first in order to induce phosphorylation at T368
by Mck1p kinase. This priming model allows Cdc6 to create Cdc4
diphospho-degrons which is an efficient Cdc4 recognition site.
David Morgan’s group shows that Eco1 is primed by CDK and
DDK in order to be targeted by Mck1, which creates Cdc4
recognition site (personal communication). Mck1 is involved in the
degradation of SCFCDC4 substrates such as Rcn1and Hsl1
[25,26,39]. Therefore, the priming model to create Cdc4 dipho-
spho-degrons seems to be a universal mechanism to regulate
protein degradation.
Mck1p protein levels are not cell cycle-regulated (data not
shown) therefore Mck1 activation is not regulated by its own
expression level. This result supports the idea of the priming
hypothesis in which Mck1 can target its substrate, Cdc6p, only
after Cdc6 is phosphorylated by cyclin/CDK in a cell cycle-
dependent manner. Given the requirement of T368 for Mck1
dependent degradation of Cdc6, Mck1 most likely phosphorylates
this residue directly in vivo. However, it is formally possible that
Mck1 affects Cdc4 function other than Cdc6. We favor the model
that Mck1 directly phosphorylates Cdc6 to promote Cdc4-
dependent degradation based on our results in Figure 5B,
Figure 7C and 7D. Whether or not SCFCDC4 or other targets
such as Sic1 are also phosphorylated by Mck1 is an interesting
future study.
The glycogen synthase kinase-3 (GSK-3) was originally identi-
fied as a kinase that inactivates glycogen synthase [40]. In higher
eukaryotes, there are two isoforms, GSK-3a and GSK-3b, that
regulate various cellular processes including Wnt signaling [41]
Figure 7. Mutations at the GSK-3 consensus site in Cdc6 play a role in Cdc6p stability. (A) GSK-3 and CDK consensus sites in the Cdc6 C-
terminal region were shown as a red and blue line, respectively. (B) The pRS426 (control plasmid), CDC6 or CDC6T368A S372A in 2micron plasmids were
transformed into ORC6-WT, ORC6-rxl, ORC6-ps or ORC6-rxl,ps mutants and plated on SD-Ura plates. Transformation efficiency for each strain was
shown as CFU/mg DNA. (C) Dmck1 cdc4-1 CDC6-prA cells (labeled as Dmck1) or cdc4-1 CDC6-prA cells (labeled as WT) were arrested during metaphase
by nocodazole for 1 hour and then temperature shifted to 37uC for 1.5 hour. Proteins were extracted and subjected to western blotting to detect
Cdc6-prA. (D) Protein extracts in Figure 7C were treated with 10 units of CIP and incubated for 10 minutes at 4 degrees. 20 ml of protein sample from
Dmck1 cells or 60 ml of protein samples from WT cells were used in order to normalize the Cdc6 protein expression. (E) An extra copy of CDC6 or
CDC6T368A was integrated into a Dmck1 GALL-MCK1 CDC6-proteinA strain at the URA locus. The resulting Dmck1 GALL-MCK1 CDC6-proteinA
URA::CDC6T368A cells were treated with nocodazole. Next, the mitotic arrested cells were incubated in YEPG to overexpress Mck1p and
supplemented with nocodazole. Cells were collected every 15 minutes. Endogenous Cdc6-proteinA or exogenous Cdc6T368A was analyzed by
western blot.
doi:10.1371/journal.pgen.1003099.g007
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and insulin signaling [42,43]. The yeast homologue of GSK3,
Mck1p, also has diverse biological functions (see introduction).
This is the first evidence to show that Mck1p or any GSK-3 kinase
controls DNA replication. Whether GSK-3 kinases contribute to




SGA analysis was performed as previously described [19,20]. A
query strain, MATalpha ORC6-rxl::LEU2 mfa::MFA1pr-HIS3 trp1
ade2 can1 leu2 his3 lys2 ura3, was placed on YEPD in rectangle
plates. Then deletion mutant arrays (MATa geneX::KanMX TRP1
ADE2 met15 leu2 ura3 his3) were put on top of the query strains.
The resulting diploid cells were sporulated on the plates containing
2% agar, 1% potassium acetate, 0.1% yeast extracts, 0.05%
glucose, supplemented with uracil and histidine. After incubation
at 22 degrees for 5 days, the spores were pinned onto haploid
selection plates (SD-His/Leu/Arg plus canavanine) to select for
MATa mfa::MFA1pr-HIS3 ORC6-rxl::LEU2 progeny, followed by
pinning onto YEPD plates containing G418 to select out the
deletion array mutants. Finally, double mutants were placed on
SD-His/Leu/Arg plus canavanine plus G418 for 2 days. The
proliferation of those that contained haploid cells was scored
visually. The deletion sets used in this study were obtained from
EuroScarf and are derivatives of BY4741 [44].
Cell cycle blocks
First, GAL-CDC6-HA or mck1 GAL-CDC6-HA strains were grown
in raffinose-containing media and then galactose was added to
express Cdc6-HA for 2 hours. The cell cycle was blocked during
mitosis by nocodazole at the concentration of 15 mg/ml for
2 hours. Next, glucose was added to the media to shut off the GAL
expression (Figure 4A). CDC6-PRA or mck1 CDC6-PRA strains were
grown in liquid YEPD to log-phase at 30 degrees and then treated
with alpha-factor at the concentration of 100 nM for 2 hours. The
cells were washed with YEPD three times to release the cell cycle
from G1. Samples were collected every 10 minutes for 80 minutes
for Figure 4B. To block the cell cycle during mitosis, CDC6-PRA or
mck1 CDC6-PRA strains were treated with nocodazole at the
concentration of 15 mg/ml for 2.5 hours at 30 degrees. The
mitotic block was released by washing cells with YEPD twice.
Samples were collected every 10 minutes for 60 minutes for
Figure 4D. For Figure 5 and 7D, cells were treated with
nocodazole for 2 hours and then switched to YEPD or YEPG
containing nocodazole at 15 mg/ml.
Plasmids and strains
All strains used, except for SGA analysis, are derivatives of
W303 (strain list in Table S1). Standard methods were used for
mating and tetrad analysis. DNA transformation was performed
by the lithium acetate method [45]. To generate mck1 or mre11
deletion in the W303 background, genes disrupted by a KanMX
cassette in BY4741 haploid deletion libraries (EuroScarf) were
amplified by PCR. The PCR product containg the KanMX cassette
with MCK1 flanking region was transformed into the wild type
W303 strain. The resulting mck1 deletion cells in W303 were
confirmed by PCR. The MCK1-MYC strain was generated by
PCR genomic integration of a PCR product containing a MYC tag
and a TRP gene [46]. GAL-CDC6DNT-HA strain and plasmid were
kindly provided by Dr. Stephen Bell. The ORC6-rxl, ORC6-ps,
ORC2-ps and MCM7-NLS mutations were described previously
[11,13,34]. CDC6-proteinA strain was generated as previously
described [47]. Rad53-FLAG strain was obtained from Dr. Petrini
[48]. To generate GALL-MCK1, MCK1 gene was cloned into
GALL-pRS405 plasmid at BamHI and SpeI sites using MCK1
plasmid provided by Dr. P. Hieter [28]. The resulting GALL-
MCK1/pRS405 plasmid was cut with BstEII, and the linearized
plasmid was transformed into bar1 mck1::KanMX CDC6-prA::HIS3
strain to integrate GALL-MCK1 at LEU locus. Cdc6-GFP strain
was made by direct transformation of a GFP cassette [49] in
BY4741 and subsequently back crossed to W303-1B three times
for Figure 4C. CDC6 plasmid was generated by PCR method using
W303 wild type genomic DNA. The resulting PCR product was
cloned into pYES2.1 Topo TA plasmid (Invitrogen) for Figure 7B.
The CDC6/pYES2.1 plasmid was subjected to site-directed
mutagenesis using QuickChange Site-directed mutagenesis kit
(Agilent Technologies, CA) to introduce T368A S372A mutation
for Figure 7B. CDC6/pRS406 plasmid was generated by PCR
cloning. CDC6 gene including the endogeneous promoter (300 bp
upstream from the start codon) was amplified by PCR using
primers that contain BamHI and XhoI, and cloned into pRS406 at
BamH1and XhoI sites. The CDC6/pRS406 plasmid was used as a
temperate to generate CDC6-T368A/pRS406. Site-directed muta-
genesis was performed as described above. The resulting plasmids
were cut with NcoI to integrate the mutated CDC6 at URA3 locus
in mck1 GALL-MCK1 CDC6-proteinA strain for Figure 7E.
Making a temperature-sensitive mutant of mck1
A temperature sensitive mutant of MCK1 was generated using a
previously described method [34]. MCK1 gene was cloned into
pRS414 at BamHI and SpeI sites from MCK1 plasmid provided by
Dr. P. Hieter [28]. The MCK1/pRS414 plasmid was mutagenized
by PCR mutagenesis to introduce random mutations in the MCK1
gene as previously described [50]. The mutagenized mck1/pRS414
plasmid was transformed into mck1 orc6-rxl strain containing
MCK1/pRS416 plasmid. The mck1 orc6-rxl cells containing
mutagenized mck1 plasmid were tested for its viability at
37 degrees. The mutagenized mck1/pRS414 plasmid (mck1-16
mutation) was isolated from the strain and was inserted into the
pRS406 plasmid at BamHI SpeI sites. The resulting mck1-16/
pRS406 plasmid was cut with BstEII restriction enzyme and was
integrated at the URA3 genome locus. Sequence analysis identified
two mutations in the temperature sensitive mck1-16 allele, resulting
in P275L and E357G.
Co-IP and Western blotting
A 50-ml culture of each strain was grown to log-phase an
OD595 of 0.5 was reached. The cell pellets were washed in cold
TE buffer, and resuspended with 400 ml of protein extraction
buffer [20 mM HEPES, pH 7.4, 110 mM potassium acetate,
2 mM MgCl2, 0.1% Tween 20, 1 mM DTT, 2 mg/ml DNaseI,
protease inhibitor cocktail (Sigma-Aldrich, MO) and phosphatase
inhibitor (Sigma-Aldrich, MO)]. Acid-washed glass beads (0.15 g)
were added, and cells were disrupted by FastPrep (MP Biomed-
icals, OH) for 20 seconds, twice, at speed 6. Samples were
centrifuged and 10 ml of supernatants were kept for Western
blotting as ‘‘INPUT’’. The remaining protein extracts were
subjected to co-immunoprecipitation (Co-IP). Agarose beads
conjugated with anti-MYC antibody (A7470) (Sigma-Aldrich,
MO) were pre-incubated with 5% BSA in protein extraction
buffer for 1 hour at 4 degrees to reduce non-specific binding first.
Then the beads were mixed with the protein extract supernatants
and rotated for 2 hours at 4 degrees. Beads were washed with
protein extraction buffer five times. After the final wash, 30 ml of
26 sample buffer was added to the beads, and the protein was
denatured at 95 degrees for 5 minutes. Proteins were separated by
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SDS-PAGE with Novex 4–20% Tris-Glycine polyacrylamide gel
(Invitrogen, CA) except Figure 7C with 7% acrylamide large gel.
The proteins on the gels were transferred to PVDF membrane
(Millipore, MA). Western blot analysis was performed using anti-
MYC antibody 9E10 (M4439) (Sigma-Aldrich, MO) at 1:4000
dilution, anti-HA antibody 3F10 (Roche, IN) at 1:4000 dilution
and anti-FLAG antibody (A8592) (Sigma-Aldrich, MO) at 1:4000
dilution. Cdc6-proteinA was visualized using anti-peroxidase
soluble complex antibody produced in rabbit (P1291) (Sigma-
Aldrich, MO) at 1:4000 dilution. Cdc6 was detected using anti-
Cdc6 antibody (9H8/5) (Abcam, MA) at 1:500 dilution.
Fluorescence microscopy
Log phase cultures of Cdc6-GFP expressing cells in SC medium
supplemented with 20 mg/L adenine were imaged live with an
Eclipse E600 fluorescence microscope (Nikon) equipped with a
DC350F CCD camera (Andor) and 1006, NA 1.45, or 606, NA
1.4, oil objectives. The images were captured with NIS-Elements
software (Nikon) and prepared using Photoshop software.
Flow cytometry
DNA content analysis by FACScanto (BD Biosciences, NJ) was
performed as described previously [51].
Yeast two-hybrid assay
The pBTM116 constructs containing various Cdc6 mutants
were obtained from Dr. J. Diffley’s lab [6]. Full length MCK1 was
cloned into pACT at BamHI and XhoI sites by PCR method. The
MCK1/pACT and each of the various CDC6/pBMT116 plasmids
were co-transformed into L40 strain and plated on SD-Leu/Trp
plates [52]. The colonies were transferred to nitrocellulose
membrane and kept at 280 degrees overnight. The membrane
was placed on whatman paper soaked with 3 ml of Z buffer,
[60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM
MgSO4] with 300 mg/ml X-gal and 0.044 M 2-mercaptoethanol.
The membrane was incubated at 30 degree overnight to visualize
the blue colonies.
Supporting Information
Figure S1 CDC6-prA or Dmck1 CDC6-prA strains were incubated
in YEPD and cell cycle arrested during mitosis using nocodazole.
CHX at the concentration of 100 ug/ml was added to the media
and samples were collected every 20 minutes. Cdc6-prA levels
were quantified and shown as a bar graph.
(TIF)
Figure S2 Genetic interactions between various CDC6 mutants
and ORC6-rxl. CDC6T368A, P369A, S372A, P373A or T368A
S372A in 2m plasmids were transformed into either wild type or
ORC6-rxl strains, and plated on YEPD plates.
(TIF)
Figure S3 Cells were treated with nocodazole first, and the
temperature was shifted to 36 degrees in order to inactivate Cdc4
function. Proteins were extracted and subjected to western blot
using direct antibody against Cdc6.
(PPT)
Table S1 Genotype of all strains used in the study. All strains
have W303 genetic background.
(PDF)
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